Mapp Biopharmaceutical
Press Inquiries
  • About Us
  • Product Development
  • News
    • In the News
    • Press Releases
  • Publications
  • Job Openings
  • Contact Us

News

BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin

November 24, 2020

PBS NewsHour – How to grow an Ebola vaccine with a tobacco plant

November 23, 2015

ZMapp™ is Granted Orphan Medicinal Product Designation by the EMA

October 15, 2015

ZMapp™ is Granted Fast Track Status by the FDA

September 17, 2015

Monoclonal Antibody-based Filovirus Therapeutic Licensed to Leaf Biopharmaceutical

July 15, 2014

Washington Post – The best innovations of 2014: ZMapp, for offering clues to a potential cure for Ebola

December 22, 2014

Status Update on ZMapp™

October 10, 2014

Consortium Wins Up to $28 Million from NIH to Find Best Proposed Ebola Treatment

March 20, 2014

International Joint Venture to Drive Commercialization of Filovirus Therapeutic via Monoclonal Antibodies

July 29, 2013

Recent News

BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin

Jan 13, 2021

BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin BARDA and its partner Mapp Biopharmaceutical Inc. will explore the potential of a new monoclonal antibody (mAb) based therapeutic for Botulinum Neurotoxin...

MappBio Announces Contract with BARDA for MBP091 as a pan-Marburg Medical Countermeasure

Jun 11, 2019

MappBio Announces Contract with BARDA for MBP091 as a pan-Marburg Medical Countermeasure June 11, 2019 – (SAN DIEGO, CA) – Mapp Biopharmaceutical, Inc. (MappBio), announced today that it has been awarded an advanced research and...

Additional Information

  • FCOI Policy
  • Purchase Order Terms and Conditions
  • Pay Transparency Nondiscrimination Provision
  • Equal Employment Opportunity is the Law
  • Institutional Biosafety Committee (NIH)
  • Employment of Individuals with Disabilities and Protected Veterans
  • Equal Employment Opportunity and Affirmative Action Policy Statement
  • Expanded Access Policy
Jobs Opportunities

© 2017-2022 Mapp Biopharmaceutical. All Rights Reserved.